CHF Solutions Revenue and Competitors

Claim your profile

Location

$22.9M

Total Funding

Estimated Revenue & Valuation

  • CHF Solutions's estimated annual revenue is currently $5.5M per year.(i)
  • CHF Solutions received $5.4M in venture funding in July 2018.
  • CHF Solutions's estimated revenue per employee is $80,882
  • CHF Solutions's total funding is $22.9M.
  • CHF Solutions's current valuation is $6.

Employee Data

  • CHF Solutions has 68 Employees.(i)
  • CHF Solutions grew their employee count by -12% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$25.1M1004%N/AN/A
#2
$5.1M5032%N/AN/A
#3
$65.3M254-1%N/AN/A
#4
$3.9M38-7%N/AN/A
#5
$4M16-24%N/AN/A
#6
$19.6M783%N/AN/A
#7
$3.9M383%N/AN/A
#8
$20.3M814%N/AN/A
#9
$15M59-2%$100MN/A
#10
$5.3M516%N/AN/A

CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis® therapy. The Aquadex FlexFlow system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's mission is to predict, measure, and control patient fluid balance through science, collaboration, and innovative medical technology. CHF Solutions is a Delaware corporation headquartered in Minneapolis, Minnesota with wholly-owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.

keywords:Healthcare,Healthcare Providers,Pharmaceuticals

$22.9M

Total Funding

68

Number of Employees

$5.5M

Revenue (est)

-12%

Employee Growth %

$6

Valuation

N/A

Accelerator

CHF Solutions News

2022-04-20 - Nuwellis Discusses REVERSE-HF Study: Assessing Heart Failure Patients with Fluid Overload

When that company was acquired, then I came to CHF Solutions at that time, that was the name of it. And looking for not necessarily any...

2022-04-19 - Rogers (VTX:ROG) Given a CHF 370 Price Target by ...

It operates through Advanced Electronics Solutions (AES), Elastomeric Material Solutions (EMS), and Other segments. The AES segment offers...

2022-04-13 - CHF Industries Selects CGS's BlueCherry® Enterprise Suite ...

The CGS BlueCherry Enterprise Suite provides clients with comprehensive digital supply chain management solutions, available both in the...

2019-09-04 - CHF Solutions, Inc. Appoints World-Renowned Heart Failure ...

CHF Solutions, Inc. Appoints World-Renowned Heart Failure Cardiologist, Maria Rosa Costanzo, M.D. to Company's Board of Directors ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.9M68N/AN/A
#2
$20.8M695%N/A
#3
$15M69-3%N/A
#4
$18.1M7049%N/A
#5
$24.1M72-13%N/A

CHF Solutions Funding

DateAmountRoundLead InvestorsReference
2011-07-26$4.6MUndisclosedSummer Street Research PartnerArticle
2011-09-22$7.4MUndisclosedStreet Research PartnersArticle
2013-04-12$13.1MUndisclosedCanaccord GenuityArticle
2015-02-20$10.0MUndisclosedSilicon Valley BankArticle
2016-07-25$3.5MUndisclosedArticle
2017-04-26$9.2MUndisclosedLadenburg Thalmann & CoArticle
2018-07-05$5.4MUndisclosedLadenburg Thalmann & CoArticle